| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,629 |
6,353 |
$566K |
| 96112 |
|
2,663 |
2,450 |
$291K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,354 |
4,487 |
$135K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,265 |
1,975 |
$116K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,334 |
1,228 |
$101K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,185 |
1,092 |
$90K |
| 99215 |
Prolong outpt/office vis |
919 |
804 |
$86K |
| 92250 |
|
1,655 |
1,461 |
$66K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
703 |
627 |
$48K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
452 |
422 |
$39K |
| 97802 |
|
1,652 |
1,462 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
330 |
311 |
$16K |
| 92551 |
|
1,792 |
1,505 |
$13K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
58 |
15 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
848 |
768 |
$11K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,347 |
950 |
$10K |
| 36410 |
|
612 |
569 |
$9K |
| 81002 |
|
2,386 |
2,094 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
2,263 |
2,079 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
197 |
171 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
365 |
268 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
120 |
107 |
$4K |
| 69210 |
|
169 |
121 |
$4K |
| 96127 |
|
1,298 |
924 |
$4K |
| 96111 |
|
67 |
38 |
$2K |
| 99173 |
|
1,281 |
1,022 |
$2K |
| 90686 |
|
1,238 |
984 |
$1K |
| 99188 |
|
125 |
122 |
$1K |
| 96161 |
|
475 |
429 |
$1K |
| 94010 |
|
29 |
28 |
$990.02 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
20 |
14 |
$985.54 |
| 36406 |
|
62 |
60 |
$854.17 |
| 90461 |
|
519 |
316 |
$851.38 |
| 94060 |
|
20 |
17 |
$682.80 |
| 90651 |
|
106 |
79 |
$643.50 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
47 |
33 |
$617.97 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
27 |
26 |
$411.21 |
| 94760 |
|
248 |
196 |
$405.31 |
| 90621 |
|
93 |
68 |
$316.66 |
| 95117 |
|
37 |
37 |
$312.80 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
20 |
18 |
$251.40 |
| 94664 |
|
20 |
18 |
$221.71 |
| 90633 |
|
36 |
31 |
$30.86 |
| A7015 |
Aerosol mask, used with dme nebulizer |
13 |
13 |
$19.88 |
| 90688 |
|
20 |
15 |
$15.45 |
| 99000 |
|
51 |
38 |
$10.00 |
| 90647 |
|
22 |
14 |
$0.00 |
| 90685 |
|
52 |
33 |
$0.00 |
| 90670 |
|
40 |
26 |
$0.00 |